Medical Information Only. Always consult your healthcare provider before enrolling in any clinical trial.
NCT01063270 · ClinicalTrials.gov registry record · NA
Trial Comparing Efficacy of Treatments for Hidradenitis Suppurativa
A NA study of Hidradenitis Suppurativa, sponsored by Henry Ford Health System.
- Completed
- Registry status
- NA
- Development phase
- 18
- Enrollment target
- 1
- Study location
NCT01063270: Completed NA study of Hidradenitis Suppurativa, sponsored by Henry Ford Health System.
NCT01063270 is a NA study of Hidradenitis Suppurativa that has completed, run by Henry Ford Health System. The registered enrollment target is 18 participants, below the 598-participant average among 52 other Hidradenitis Suppurativa trials with a reported enrollment target (97% lower). The trial reports 1 study location across 1 state. According to ClinicalTrials.gov, the official US trial registry.
The verdict
NCT01063270, a NA study of Hidradenitis Suppurativa, has completed, sponsored by Henry Ford Health System.
- COMPLETED
- Registry status
- NA
- Development phase
- 18 participants
- Enrollment target
- 1
- Study location
Study Summary
The purpose of this research study is to further evaluate the efficacy of two treatment regimens for the treatment of hidradenitis suppurativa. This is a randomized controlled study. Patients will be randomly assigned to an arm of the study.
Conditions Studied
Interventions
- DRUG Clindamycin & Rifampin
- PROCEDURE Clindamycin + Rifampin along with NdYag Laser treatment
Study Locations (1)
Michigan
- Henry Ford Hospital Department of Dermatology. 3031 West Grand Blvd, Suite 800 - Detroit
Trial Details
| Field | Value |
|---|---|
| Enrollment Target | 18 participants |
| Start Date | 2010-02 |
| Est. Completion | 2013-12 |
| Phase | NA |
What the finished NCT01063270 record still lists
NCT01063270 is an interventional study that assigns participants to a tested intervention. The registry caps enrollment at 18 participants, a relatively small participant target, below the 598-participant average among 52 other Hidradenitis Suppurativa trials with a reported enrollment target (97% lower).
The record links to 1 condition, with Hidradenitis Suppurativa appearing as the primary indexed condition, and to 2 interventions - of which Clindamycin & Rifampin is the first listed.
NCT01063270 reports a single indexed study location in Michigan.
Frequently Asked Questions
What is clinical trial NCT01063270 about?
NCT01063270 is a clinical study titled "Trial Comparing Efficacy of Treatments for Hidradenitis Suppurativa". The purpose of this research study is to further evaluate the efficacy of two treatment regimens for the treatment of hidradenitis suppurativa. This is a randomized controlled study. Patients will be randomly assigned to an arm of the study.
What is the current status of trial NCT01063270?
This trial is currently completed. It is a NA study. The enrollment target is 18 participants. The study started on 2010-02. Estimated completion is 2013-12.
What conditions does trial NCT01063270 study?
This clinical trial studies the following conditions: Hidradenitis Suppurativa.
What interventions are being tested in trial NCT01063270?
The interventions under investigation include: Clindamycin & Rifampin (DRUG), Clindamycin + Rifampin along with NdYag Laser treatment (PROCEDURE).
Who is sponsoring clinical trial NCT01063270?
This trial is sponsored by Henry Ford Health System, which has 234 total clinical trials registered on ClinicalTrials.gov.
Where is trial NCT01063270 being conducted?
This trial has 1 study location across Michigan. Contact the study sites directly through ClinicalTrials.gov for enrollment availability.
Learn More About Clinical Trials
Similar trials for Hidradenitis Suppurativa
Matched on the same primary condition, ranked to surface studies in the same phase first, then by recruiting status, no relevance scoring or editorial curation.
Where NCT01063270's enrollment target sits among peer trials
18 45th of 52 higher than 8 of 52 other Hidradenitis Suppurativa trials
participants (enrollment target), bucketed by value
Each bar is a band; taller bars hold more other Hidradenitis Suppurativa trials. The dashed line + filled bar mark this entry. Hover or tap any bar for its full count and share, and where it sits relative to this entry.
Source ClinicalTrials.gov registry export · 2026-08-08
-
Aviclear for Hidradenitis Suppurativa (HS)
RECRUITING · NA
-
Physical Activity in Hidradenitis Suppurativa (HS)
RECRUITING · NA
-
Battlefield Acupuncture for Pain in Hidradenitis Suppurativa
RECRUITING · NA
-
Feasibility Study on Radiofrequency-Based Selective Electrothermolysis to Investigate Its Effects on Human Skin
RECRUITING · NA
-
Study on the Effect of NdYag Laser for the Treatment of Hidradenitis Suppurativa
COMPLETED · NA
-
Hidradenitis Suppurativa (HS) Tunneling Wounds
COMPLETED · NA
Nationwide trials with similar profiles
Cross-condition peers matched on enrollment target and registry start date, not the same-condition list above.
Similar enrollment target
- NCT01245179 · 18 participants · Phase 1
Study of Panobinostat (LBH589) in Patients With Sickle Cell Disease
- NCT01999361 · 18 participants · NA
Prevention of de Novo Allosensitization in Islet Transplant Recipients Following Complete Graft Loss
- NCT02359825 · 18 participants · Phase 1
Nerve Repair Using Hydrophilic Polymers to Promote Immediate Fusion of Severed Axons and Swift Return of Function
- NCT02870244 · 18 participants · Phase 1
Adoptive T Cell Immunotherapy for Advanced Melanoma Using Engineered Lymphocytes
Similar registry start date
- NCT05988463 · started 2027-01-01 · Phase 1
Dose-Escalation Study of Artesunate Patients With IPF
- NCT07219706 · started 2026-12-10 · NA
Dietary Fiber and Time Restricted Eating
- NCT02831335 · started 2026-12-01
Technical Development of Multi-Parametric Renocerebral MRI
- NCT05962346 · started 2026-12 · NA
Fetal Endoscopic Tracheal Occlusion for Congenital Diaphragmatic Hernia